Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 228

1.

Angiostrongylus cantonensis: a review of its distribution, molecular biology and clinical significance as a human pathogen - CORRIGENDUM.

Barratt JL, Ellis J.

Parasitology. 2019 Jul 22:1. doi: 10.1017/S003118201900101X. [Epub ahead of print] No abstract available.

PMID:
31327329
2.

Association between native T1 mapping of the kidney and renal fibrosis in patients with IgA nephropathy.

Graham-Brown MP, Singh A, Wormleighton J, Brunskill NJ, McCann GP, Barratt J, Burton JO, Xu G.

BMC Nephrol. 2019 Jul 11;20(1):256. doi: 10.1186/s12882-019-1447-2.

3.

Mitochondrial Junction Region as Genotyping Marker for Cyclospora cayetanensis.

Nascimento FS, Barta JR, Whale J, Hofstetter JN, Casillas S, Barratt J, Talundzic E, Arrowood MJ, Qvarnstrom Y.

Emerg Infect Dis. 2019 Jul;25(7):1314-1319. doi: 10.3201/eid2507.181447.

4.

Genotyping Genetically Heterogeneous Cyclospora cayetanensis Infections to Complement Epidemiological Case Linkage.

Barratt JLN, Park S, Nascimento FS, Hofstetter J, Plucinski M, Casillas S, Bradbury RS, Arrowood MJ, Qvarnstrom Y, Talundzic E.

Parasitology. 2019 May 31:1-33. doi: 10.1017/S0031182019000581. [Epub ahead of print] No abstract available.

PMID:
31148531
5.

The Iron Biology Status of Peritoneal Dialysis Patients May Be a Risk Factor for Development of Infectious Peritonitis.

Aldriwesh M, Al-Dayan N, Barratt J, Freestone P.

Perit Dial Int. 2019 Jul-Aug;39(4):362-374. doi: 10.3747/pdi.2018.00052. Epub 2019 May 23.

PMID:
31123076
6.

Standardized Outcomes in Nephrology-Glomerular Disease (SONG-GD): establishing a core outcome set for trials in patients with glomerular disease.

Carter SA, Lightstone L, Cattran D, Bagga A, Barbour SJ, Barratt J, Boletis J, Caster D, Coppo R, Fervenza FC, Floege J, Hladunewich M, Hogan JJ, Kitching AR, Lafayette R, Malvar A, Radhakrishnan J, Rovin BH, Zhang H, Gutman T, Howell M, Logeman C, Shen JI, Teixeira-Pinto A, Alexander SI, Cho Y, Craig JC, Harris D, Johnson DW, Kerr PG, Ryan J, Viecelli AK, Wang AY, Wilkie M, Scholes-Robertson N, Tong A; SONG-GD Initiative.

Kidney Int. 2019 Jun;95(6):1280-1283. doi: 10.1016/j.kint.2019.01.047. No abstract available.

PMID:
31122702
7.

Biological variation of measured and estimated glomerular filtration rate in patients with chronic kidney disease.

Rowe C, Sitch AJ, Barratt J, Brettell EA, Cockwell P, Dalton RN, Deeks JJ, Eaglestone G, Pellatt-Higgins T, Kalra PA, Khunti K, Loud FC, Morris FS, Ottridge RS, Stevens PE, Sharpe CC, Sutton AJ, Taal MW, Lamb EJ; eGFR-C study group.

Kidney Int. 2019 Mar 7. pii: S0085-2538(19)30274-1. doi: 10.1016/j.kint.2019.02.021. [Epub ahead of print]

PMID:
31084924
8.

Is immunoglobulin A nephropathy different in different ethnic populations?

Yeo SC, Goh SM, Barratt J.

Nephrology (Carlton). 2019 Apr 11. doi: 10.1111/nep.13592. [Epub ahead of print] Review.

PMID:
30977248
9.

IgA nephropathy: "State of the art": a report from the 15th International Symposium on IgA Nephropathy celebrating the 50th anniversary of its first description.

Trimarchi H, Barratt J, Monteiro RC, Feehally J.

Kidney Int. 2019 Apr;95(4):750-756. doi: 10.1016/j.kint.2019.01.007.

PMID:
30904065
10.

Galactose deficient IgA1 (GD-IgA1) in skin and serum from patients with skin-limited and systemic IgA Vasculitis.

Neufeld M, Molyneux K, Pappelbaum KI, Mayer-Hain S, von Hodenberg C, Ehrchen J, Barratt J, Suzuki Y, Sunderkötter C.

J Am Acad Dermatol. 2019 Mar 19. pii: S0190-9622(19)30443-8. doi: 10.1016/j.jaad.2019.03.029. [Epub ahead of print]

PMID:
30902725
11.

Use of Medicines that May Exacerbate Heart Failure in Older Adults: Therapeutic Complexity of Multimorbidity.

Caughey GE, Shakib S, Barratt JD, Roughead EE.

Drugs Aging. 2019 May;36(5):471-479. doi: 10.1007/s40266-019-00645-0.

PMID:
30875020
12.

Latin American Adult Immunisation Advocacy Summit: Overcoming regional barriers to adult vaccination.

Barratt J, Mishra V, Acton M.

Aging Clin Exp Res. 2019 Mar;31(3):339-344. doi: 10.1007/s40520-019-01156-z. Epub 2019 Mar 11.

PMID:
30859460
13.

Pregnancy in IgA Nephropathy: An Effect on Renal Outcome?

Cheung CK, Barratt J.

Am J Nephrol. 2019;49(3):212-213. doi: 10.1159/000495882. Epub 2019 Feb 26. No abstract available.

14.

New strategies and perspectives on managing IgA nephropathy.

Selvaskandan H, Cheung CK, Muto M, Barratt J.

Clin Exp Nephrol. 2019 May;23(5):577-588. doi: 10.1007/s10157-019-01700-1. Epub 2019 Feb 13.

15.

The complete coding region of the maxicircle as a superior phylogenetic marker for exploring evolutionary relationships between members of the Leishmaniinae.

Kaufer A, Barratt J, Stark D, Ellis J.

Infect Genet Evol. 2019 Jun;70:90-100. doi: 10.1016/j.meegid.2019.02.002. Epub 2019 Feb 7.

PMID:
30738194
16.

Systematic review of prehospital haemostatic dressings.

Welch M, Barratt J, Peters A, Wright C.

J R Army Med Corps. 2019 Feb 2. pii: jramc-2018-001066. doi: 10.1136/jramc-2018-001066. [Epub ahead of print]

PMID:
30711924
17.

Proteinuria Reduction as a Surrogate End Point in Trials of IgA Nephropathy.

Thompson A, Carroll K, A Inker L, Floege J, Perkovic V, Boyer-Suavet S, W Major R, I Schimpf J, Barratt J, Cattran DC, S Gillespie B, Kausz A, W Mercer A, Reich HN, H Rovin B, West M, Nachman PH.

Clin J Am Soc Nephrol. 2019 Mar 7;14(3):469-481. doi: 10.2215/CJN.08600718. Epub 2019 Jan 11.

PMID:
30635299
18.

Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update.

Coppo R, D'Arrigo G, Tripepi G, Russo ML, Roberts ISD, Bellur S, Cattran D, Cook TH, Feehally J, Tesar V, Maixnerova D, Peruzzi L, Amore A, Lundberg S, Di Palma AM, Gesualdo L, Emma F, Rollino C, Praga M, Biancone L, Pani A, Feriozzi S, Polci R, Barratt J, Del Vecchio L, Locatelli F, Pierucci A, Caliskan Y, Perkowska-Ptasinska A, Durlik M, Moggia E, Ballarin JC, Wetzels JFM, Goumenos D, Papasotiriou M, Galesic K, Toric L, Papagianni A, Stangou M, Benozzi L, Cusinato S, Berg U, Topaloglu R, Maggio M, Ots-Rosenberg M, D'Amico M, Geddes C, Balafa O, Quaglia M, Cravero R, Lino Cirami C, Fellstrom B, Floege J, Egido J, Mallamaci F, Zoccali C.

Nephrol Dial Transplant. 2018 Nov 9. doi: 10.1093/ndt/gfy302. [Epub ahead of print]

PMID:
30418652
19.

Nurse practitioner consultations in primary health care: patient, carer, and nurse practitioner qualitative interpretations of communication processes.

Barratt J, Thomas N.

Prim Health Care Res Dev. 2018 Oct 31:1-9. doi: 10.1017/S1463423618000798. [Epub ahead of print]

20.

Protocol and rationale for the first South Asian 5-year prospective longitudinal observational cohort study and biomarker evaluation investigating the clinical course and risk profile of IgA nephropathy: GRACE IgANI cohort.

Alexander S, John GT, Korula A, Vijayakumar TS, David VG, Mohapatra A, Valson AT, Jacob S, Koshy PM, Rajan G, John EE, Matthai SM, Jeyaseelan L, Ponnusamy B, Cook T, Pusey C, Daha MR, Feehally J, Barratt J, Varughese S.

Wellcome Open Res. 2018 Jul 26;3:91. doi: 10.12688/wellcomeopenres.14644.1. eCollection 2018.

21.

Restriction enzyme digestion of host DNA enhances universal detection of parasitic pathogens in blood via targeted amplicon deep sequencing.

Flaherty BR, Talundzic E, Barratt J, Kines KJ, Olsen C, Lane M, Sheth M, Bradbury RS.

Microbiome. 2018 Sep 17;6(1):164. doi: 10.1186/s40168-018-0540-2.

22.

Treatment of IgA Nephropathy: Evolution Over Half a Century.

Barratt J, Tang SCW.

Semin Nephrol. 2018 Sep;38(5):531-540. doi: 10.1016/j.semnephrol.2018.05.023. Review.

PMID:
30177025
23.

Aberrant Glycosylation of the IgA1 Molecule in IgA Nephropathy.

Novak J, Barratt J, Julian BA, Renfrow MB.

Semin Nephrol. 2018 Sep;38(5):461-476. doi: 10.1016/j.semnephrol.2018.05.016. Review.

PMID:
30177018
24.

Genome Wide Identification of Mutational Hotspots in the Apicomplexan Parasite Neospora caninum and the Implications for Virulence.

Calarco L, Barratt J, Ellis J.

Genome Biol Evol. 2018 Sep 1;10(9):2417-2431. doi: 10.1093/gbe/evy188.

25.

Nurse practitioner consultations in primary health care: an observational interaction analysis of social interactions and consultation outcomes - ERRATUM.

Barratt J, Thomas N.

Prim Health Care Res Dev. 2018 Aug 30:1. doi: 10.1017/S1463423618000634. [Epub ahead of print] No abstract available.

26.

Study protocol: responding to the needs of patients with IgA nephropathy, a social media approach.

Graham-Brown MPM, Vasilica C, Oates T, Light B, Clausner C, Antonacoloulos A, Chen LYJ, Ormandy P, Barratt J.

Clin Kidney J. 2018 Aug;11(4):474-478. doi: 10.1093/ckj/sfx131. Epub 2017 Nov 23.

27.

Reducing hypnotic use in insomnia management among Australian veterans: results from repeated national interventions.

Kalisch Ellett LM, Lim R, Pratt NL, Kerr M, Ramsay EN, LeBlanc TV, Barratt JD, Roughead EE.

BMC Health Serv Res. 2018 Aug 9;18(1):626. doi: 10.1186/s12913-018-3443-9.

28.
29.

Global perspectives on the provision of diabetic retinopathy screening and treatment: Survey of health care professionals in 41 countries.

Cavan D, Makaroff LE, da Rocha Fernandes J, Karuranga S, Sylvanowicz M, Conlon J, Chaney D, Malhi A, Barratt J.

Diabetes Res Clin Pract. 2018 Sep;143:170-178. doi: 10.1016/j.diabres.2018.07.004. Epub 2018 Jul 10.

PMID:
30003940
30.

Nurse practitioner consultations in primary health care: an observational interaction analysis of social interactions and consultation outcomes.

Barratt J, Thomas N.

Prim Health Care Res Dev. 2018 Jul 6:1-11. doi: 10.1017/S1463423618000427. [Epub ahead of print] Erratum in: Prim Health Care Res Dev. 2018 Aug 30;:1.

31.

Aging Health and R&D for Healthy Longevity Must Be Included into the WHO Work Program.

Stambler I, Jin K, Lederman S, Barzilai N, Olshansky SJ, Omokaro E, Barratt J, Anisimov VN, Rattan S, Yang S, Forster M, Byles J.

Aging Dis. 2018 Apr 1;9(2):331-333. doi: 10.14336/AD.2017.1120. eCollection 2018 Apr. No abstract available.

32.

The validity of the Rx-Risk Comorbidity Index using medicines mapped to the Anatomical Therapeutic Chemical (ATC) Classification System.

Pratt NL, Kerr M, Barratt JD, Kemp-Casey A, Kalisch Ellett LM, Ramsay E, Roughead EE.

BMJ Open. 2018 Apr 13;8(4):e021122. doi: 10.1136/bmjopen-2017-021122.

33.

Adult immunisation: A key element of public health programs: Synopsis of Asia Pacific Adult Immunisation Meeting, Tokyo, 1-2 December 2016.

Rochman-Fowler J, Duarte Walsh V, Barratt J.

Australas J Ageing. 2018 Jun;37(2):151-154. doi: 10.1111/ajag.12529. Epub 2018 Apr 5.

PMID:
29623682
34.

Collaborative communication: learning from advanced clinical practice patient consultations.

Barratt J.

Nurs Stand. 2018 Apr 28;33(1):27-32. doi: 10.7748/ns.2018.e11094. Epub 2018 Mar 27.

PMID:
29583172
35.

A qualitative study of the perspectives of key stakeholders on the delivery of clinical academic training in the East Midlands.

Green RH, Evans V, MacLeod S, Barratt J.

JRSM Open. 2018 Feb 19;9(2):2054270417741843. doi: 10.1177/2054270417741843. eCollection 2018 Feb.

36.

MicroRNAs: a new avenue to understand, investigate and treat immunoglobulin A nephropathy?

Selvaskandan H, Pawluczyk I, Barratt J.

Clin Kidney J. 2018 Feb;11(1):29-37. doi: 10.1093/ckj/sfx096. Epub 2017 Sep 23.

37.

Report on WHO meeting on immunization in older adults: Geneva, Switzerland, 22-23 March 2017.

Teresa Aguado M, Barratt J, Beard JR, Blomberg BB, Chen WH, Hickling J, Hyde TB, Jit M, Jones R, Poland GA, Friede M, Ortiz JR.

Vaccine. 2018 Feb 8;36(7):921-931. doi: 10.1016/j.vaccine.2017.12.029. Epub 2018 Jan 12.

38.

Targeted-release budesonide therapy for IgA nephropathy - Authors' reply.

Fellström B, Barratt J, Flöge J, Jardine A.

Lancet. 2017 Dec 16;390(10113):2625-2626. doi: 10.1016/S0140-6736(17)32138-4. No abstract available.

PMID:
29256402
39.

Reduced proximal tubular expression of protein endocytic receptors in proteinuria is associated with urinary receptor shedding.

Fatah H, Benfaed N, Chana RS, Chunara MH, Barratt J, Baines RJ, Brunskill NJ.

Nephrol Dial Transplant. 2018 Jun 1;33(6):934-943. doi: 10.1093/ndt/gfx321.

PMID:
29186471
40.

The Effect of Resistance Exercise on Inflammatory and Myogenic Markers in Patients with Chronic Kidney Disease.

Watson EL, Viana JL, Wimbury D, Martin N, Greening NJ, Barratt J, Smith AC.

Front Physiol. 2017 Jul 28;8:541. doi: 10.3389/fphys.2017.00541. eCollection 2017.

41.

β1,4-galactosyltransferase 1 is a novel receptor for IgA in human mesangial cells.

Molyneux K, Wimbury D, Pawluczyk I, Muto M, Bhachu J, Mertens PR, Feehally J, Barratt J.

Kidney Int. 2017 Dec;92(6):1458-1468. doi: 10.1016/j.kint.2017.05.002. Epub 2017 Jul 24.

PMID:
28750925
42.

New insights into the pathogenesis of IgA nephropathy.

Yeo SC, Cheung CK, Barratt J.

Pediatr Nephrol. 2018 May;33(5):763-777. doi: 10.1007/s00467-017-3699-z. Epub 2017 Jun 17. Review.

43.

Assessing the stability and suitability of haematology parameters for diagnosing and monitoring iron deficiency.

Sellors A, Melbourne J, Barratt J, Barton L.

Int J Lab Hematol. 2017 Oct;39(5):e132-e134. doi: 10.1111/ijlh.12702. Epub 2017 Jun 9. No abstract available.

PMID:
28598029
44.

The evolution of trypanosomatid taxonomy.

Kaufer A, Ellis J, Stark D, Barratt J.

Parasit Vectors. 2017 Jun 8;10(1):287. doi: 10.1186/s13071-017-2204-7. Review.

45.

Apixaban, concomitant medicines and spontaneous reports of haemorrhagic events.

Caughey GE, Kalisch Ellett LM, Barratt JD, Shakib S.

Ther Adv Drug Saf. 2017 May;8(5):157-164. doi: 10.1177/2042098616689771. Epub 2017 Feb 10.

46.

The Diabetic Retinopathy Barometer Study: Global perspectives on access to and experiences of diabetic retinopathy screening and treatment.

Cavan D, Makaroff L, da Rocha Fernandes J, Sylvanowicz M, Ackland P, Conlon J, Chaney D, Malhi A, Barratt J.

Diabetes Res Clin Pract. 2017 Jul;129:16-24. doi: 10.1016/j.diabres.2017.03.023. Epub 2017 Apr 4.

PMID:
28499163
47.

Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial.

Fellström BC, Barratt J, Cook H, Coppo R, Feehally J, de Fijter JW, Floege J, Hetzel G, Jardine AG, Locatelli F, Maes BD, Mercer A, Ortiz F, Praga M, Sørensen SS, Tesar V, Del Vecchio L; NEFIGAN Trial Investigators.

Lancet. 2017 May 27;389(10084):2117-2127. doi: 10.1016/S0140-6736(17)30550-0. Epub 2017 Mar 28.

PMID:
28363480
48.

Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group.

Trimarchi H, Barratt J, Cattran DC, Cook HT, Coppo R, Haas M, Liu ZH, Roberts IS, Yuzawa Y, Zhang H, Feehally J; IgAN Classification Working Group of the International IgA Nephropathy Network and the Renal Pathology Society; Conference Participants.

Kidney Int. 2017 May;91(5):1014-1021. doi: 10.1016/j.kint.2017.02.003. Epub 2017 Mar 22. Review.

49.

Posttraumatic Stress Disorder, Antipsychotic Use and Risk of Dementia in Veterans.

Roughead EE, Pratt NL, Kalisch Ellett LM, Ramsay EN, Barratt JD, Morris P, Killer G.

J Am Geriatr Soc. 2017 Jul;65(7):1521-1526. doi: 10.1111/jgs.14837. Epub 2017 Mar 17.

PMID:
28306156
50.

Understanding 30-day re-admission after hospitalisation of older patients for diabetes: identifying those at greatest risk.

Caughey GE, Pratt NL, Barratt JD, Shakib S, Kemp-Casey AR, Roughead EE.

Med J Aust. 2017 Mar 6;206(4):170-175.

PMID:
28253467

Supplemental Content

Loading ...
Support Center